Atai stock forecast.

As of the end of March 2023, the ETF’s portfolio worth fell to $7.4 billion, as Cathie Wood started to sell stocks last year. According to a Bloomberg report, because of selling stocks at a loss ...Down -34.59% in 4 Weeks, Here's Why You Should You Buy the Dip in atai Life Sciences N.V. (ATAI) Zacks - Tue Jan 31, 8:35AM CST . atai Life Sciences N.V. (ATAI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings... Atai Life Sciences Nv (ATAI) Share Price Forecast. Currently 15 wall-street analysts regularly analyze the financials of Atai Life Sciences Nv on a frequent basis to provide recommendations along with target share price. 15 analysts offering 12-month price forecasts for Atai Life Sciences Nv (ATAI) have a share price target of $12.32. NL0015000DX5. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Show more.

30. 8. 2022. ... Wall Street's 12-month median price forecast for ATAI stock stands at $24.50. Compass Pathways (CMPS). magic mushrooms representing champion ...

-15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. (ATAI) NasdaqGM - NasdaqGM Real Time Price. Currency in... As of last trade ATAI Life Sciences NV (ATAI:NMQ) traded at 1.10, 4.76% above its 52-week low of 1.05, set on Oct 27, 2023. Data delayed at least 15 minutes, as of Nov 30 2023 18:35 GMT. Latest ATAI Life Sciences NV (ATAI:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and …

Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ...WebShares of the Peter Thiel -backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling ...NL0015000DX5. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Show more.Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00. Find real-time CYBN - Cybin Inc stock quotes, company profile, news and forecasts from CNN Business.

Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00.

As of last trade ATAI Life Sciences NV (ATAI:NMQ) traded at 1.10, 4.76% above its 52-week low of 1.05, set on Oct 27, 2023. Data delayed at least 15 minutes, as of Nov 30 2023 18:35 GMT. Latest ATAI Life Sciences NV (ATAI:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and …

The highest rated platform for investors in the world! TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. TipRanks stock market research and analysis, lets you see the track record and measured performance of any analyst or blogger, so you know who to trust!ATAI stock closed at $1.76 and is up $0.10 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a strong overall score of 70 meaning the stock holds a better value than 70% of stocks at its current price.Nov 29, 2023 · Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ... Complete ATAI Life Sciences N.V. stock information by Barron's. View real-time ATAI stock price and news, along with industry-best analysis. The average Atai Life Sciences Nv stock price prediction forecasts a potential upside of 1,490.91% from the current ATAI share price of $1.10. What is ATAI's forecast return on equity (ROE) for 2023-2026?Detailed statistics for Atai Life Sciences N.V. (ATAI) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The ...

According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.November 30, 2023. EPS forecast (this quarter) -$1.25. Annual revenue (last year) $244.7M. Annual profit (last year) -$358.7M. Net profit margin. On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until the 2024 annual meeting of the Company’s stockholders, or until their respective successors are duly elected and qualified.Mind Medicine (MNMD) is a biotech company that develops psychedelic-inspired therapies for mental health disorders. Find out how analysts rate the stock and what are its growth prospects on TipRanks.com. You can also access the latest earnings reports, forecasts, and price movements of MNMD on the same platform.---Don't miss this opportunity to …CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93.Historical and current end-of-day data provided by . All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday ...

Atai Life stock slumps 40% as depression drug fails mid-stage study. Jan. 06, 2023 8:23 AM ET Atai Life Sciences N.V. (ATAI) By: Ravikash, SA News Editor 11 Comments. Sean Anthony Eddy. Atai Life ...Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...

View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.ADMA Stock 12 Months Forecast. $6.00. (51.90% Upside) Based on 2 Wall Street analysts offering 12 month price targets for ADMA Biologics in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 51.90% change from the last price of $3.95.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Aptinyx Inc APTX Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.According to Atai Life Sciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.18478. At the end of ...30. 3. 2023. ... Psychedelic Stocks' Promising Outlook For Investors - Psychedelics Exclusive ... atai Founder Reveals 14 Reasons To Remain Optimistic - TDR ...3. 4. 2023. ... As atai currently has a stock price of $1.83 and a market cap of $304 million. Meaning it is trading at a 14% discount. And again, that ...Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.November 30, 2023. EPS forecast (this quarter) -$1.25. Annual revenue (last year) $244.7M. Annual profit (last year) -$358.7M. Net profit margin.SVRA Stock 12 Months Forecast. $6.67. (79.30% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Savara in the last 3 months. The average price target is $6.67 with a high forecast of $7.00 and a low forecast of $6.00. The average price target represents a 79.30% change from the last price of $3.72.

Find the latest Mind Medicine (MindMed) Inc. (MNMD) stock quote, history, news and other vital information to help you with your stock trading and investing.

The Plug Power stock price fell by -2.38% on the last day (Wednesday, 22nd Nov 2023) from $3.57 to $3.48. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 5.97% from a day low at $3.44 to a day high of $3.64. The price has fallen in 8 of the last 10 days and is down by -42.19% for this period.

Their CMPS share price targets range from $19.00 to $120.00. On average, they anticipate the company's stock price to reach $46.83 in the next year. This suggests a possible upside of 683.2% from the stock's current price. View analysts price targets for CMPS or view top-rated stocks among Wall Street analysts.Fast-forward to 2023, and the accelerating adoption of generative AI caused a rapid reversal of fortunes, and Palantir is back in investors' good graces. With a current …WebMay 25, 2023 · These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ... Part of ATAI stock’s negative performance can be attributed to some poor clinical trial results. The company began the year by announcing disappointing news regarding a Phase 2 trial for PCN-101 ...Jun 2, 2022 · Shares of mental health biopharma Atai Life Sciences N.V. have fallen some two-thirds from their June 2021 IPO pricing as the biotech market continues to crater. See why ATAI stock is a buy. Analyst Recommendations on Atai Life Sciences N.V. Berenberg Bank Adjusts Atai Life Sciences Price Target to $11 From $18, Maintains Buy Rating. Mar. 29. MT. Credit Suisse Lowers Atai Life Sciences' PT to $9 From $11, Updates Model After Announced Workforce Reduction; Keeps Outperform Rating. Mar. 07.When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Jul 10, 2023 · On July 10, 2023, the stock experienced a significant increase, driven by positive forecasts and a strong consensus among investment analysts. According to data from CNN Money, the 12-month price forecasts for ATAI stock have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00.

The ATA Inc. stock price gained 7.69% on the last trading day (Friday, 1st Dec 2023), rising from $1.04 to $1.12. During the last trading day the stock fluctuated 12.20% from a day low at $1.03 to a day high of $1.15. The price has risen in 5 of the last 10 days and is up by 0.9% over the past 2 weeks. Volume fell on the last day by -2 million ...4 brokers have issued 1-year price targets for Atai Life Sciences' stock. Their ATAI share price targets range from $9.00 to $20.00. On average, they expect the …WebNov 17, 2023 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst rating ... Instagram:https://instagram. schwab schdget a home loan with a 500 credit scorenyse pfe comparechubb homeowners insurance Historical and current end-of-day data provided by . All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday ... chance of government shutdownaapl divident ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary. 15. 6. 2021. ... Since Atai Life Sciences is only going public, we don't have any forecast for the stock. Also, being a clinical-stage company, we don't have ... best real estate crowdfunding sites ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ...The sector offers explosive growth potential, evidenced by the recent positive coverage of psychedelic stocks by investment research firms like Citi, Credit Suisse, Canaccord Genuity, and Cantor ...ATAI identifies promising mental health technologies or drugs and then acquires a stock interest, providing technical and financial support to hasten the time to market.